|
Volumn 41, Issue 111, 1997, Pages 146-148
|
Pharmacovigilance and safety aspects of sevoflurane
|
Author keywords
[No Author keywords available]
|
Indexed keywords
SEVOFLURANE;
2,2 DIFLUORO 1 (TRIFLUOROMETHYL)VINYL FLUOROMETHYL ETHER;
ETHER DERIVATIVE;
FLUORIDE;
FLUORINATED HYDROCARBON;
FLUOROMETHYL 2,2-DIFLUORO-1-(TRIFLUOROMETHYL)VINYL ETHER;
INHALATION ANESTHETIC AGENT;
ANESTHESIA;
ANESTHESIOLOGY;
CONFERENCE PAPER;
DRUG MONITORING;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
NEPHROTOXICITY;
NONHUMAN;
PRIORITY JOURNAL;
ADULT;
ARTICLE;
CHILD;
DRUG EFFECT;
DRUG SCREENING;
DRUG SURVEILLANCE PROGRAM;
HEART;
HUMAN;
KIDNEY;
METABOLISM;
METHODOLOGY;
POSTMARKETING SURVEILLANCE;
SAFETY;
TOXIC HEPATITIS;
UNITED STATES;
ADULT;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
ANESTHETICS, INHALATION;
CHILD;
DRUG EVALUATION;
ETHERS;
FLUORIDES;
HEART;
HEPATITIS, TOXIC;
HUMANS;
HYDROCARBONS, FLUORINATED;
KIDNEY;
METHYL ETHERS;
PRODUCT SURVEILLANCE, POSTMARKETING;
SAFETY;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 0031308776
PISSN: 05152720
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (41)
|